Works matching IS 03424642 AND DT 2003 AND VI 29 AND IP 6


Results: 36
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14

    Drotrecogin alfa (activated) in the treatment of severe sepsis patients with multiple-organ dysfunction: data from the PROWESS trial.

    Published in:
    2003
    By:
    • Dhainaut, Jean-François;
    • Laterre, Pierre-François;
    • Janes, Jonathan M.;
    • Bernard, Gordon R.;
    • Artigas, Antonio;
    • Bakker, Jan;
    • Riess, Hanno;
    • Basson, Bruce R.;
    • Charpentier, Julien;
    • Utterback, Barbara G.;
    • Vincent, Jean-Louis;
    • Dhainaut, Jean-François;
    • Laterre, Pierre-François;
    • Recombinant Human Activated Protein C Worldwide Evaluation in Sepsis (PROWESS) Study Group;
    • Recombinant Human Activated Protein C Worldwide Evaluation in Severe Sepsis (PROWESS) Study Group
    Publication type:
    journal article
    15
    16
    17
    18
    19
    20
    22
    23
    24
    25
    26
    27
    28

    June 2003.

    Published in:
    Intensive Care Medicine, 2003, v. 29, n. 6, p. 1033, doi. 10.1007/s00134-003-1841-9
    Publication type:
    Article
    29
    30
    31
    32
    33
    34
    35
    36